Remove 2023 Remove Chronic pain management Remove Digital Health Remove Leadership
article thumbnail

Average Multiples and Key Drivers of Digital Therapeutics (DTx) M&A deals in 2023

Lloyd Price

Executive Summary: The average multiples for digital therapeutics (DTx) M&A deals in 2023 are as follows: Enterprise value (EV) to sales: 5.6x Here are some additional insights into DTx M&A deals in 2023: The most active acquirers in the DTx M&A market are pharmaceutical companies, followed by technology companies.

article thumbnail

Kanabo Group Appoints Ian Mattioli as Chair of the Board and Secures a £2.5M Minimum Investment Round

Digital Health Global

This funding will support Kanabo’s UK market expansion, further developing its telehealth offering, and accelerating the integration of additional treatments into its digital health platform and medical cannabis product line. His appointment will substantially boost our expansion plans in the digital healthcare sector.

article thumbnail

Third Culture Capital Leads Latest Funding Round for Ciba Health

Digital Health Global

3CC Founder and Managing Partner Julien L. While Ciba Health has been fortunate to have positively impacted thousands of lives through our targeted programs, we look forward to changing even more lives for the better in the future.” Prior to Ciba Health, Clement co-founded Kaia Health Inc.,